Control of inflammation using non-invasive neuromodulation: past, present and promise

Aisling Tynan(Northwell Health), Sangeeta S. Chavan(Feinstein Institute for Medical Research), Michael Brines(Northwell Health)
International Immunology
September 20, 2021
10.1093/intimm/dxab073
Cited by 47

Related Papers

Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Erythropoietin Therapy for Acute Stroke Is Both Safe and Beneficial
|Molecular Medicine|2002|1k
Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress
|Proceedings of the National Academy of Sciences|2001|1k
Derivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic
|Science|2004|800
Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptor
|Proceedings of the National Academy of Sciences|2004|654